Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

NOT YET RECRUITING

NCT06715189

Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

Sponsor: Sohag University

View on ClinicalTrials.gov

Summary

Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus

Official title: Correlation Between Serum Adiponectin and Resistin Levels and Degree of Hepatic Fibrosis In Metabolic Dysfunction _Associated Steatotic Liver Disease (MASLD)With Type2 Diabetes Mellitus

Key Details

Gender

All

Age Range

30 Years - 65 Years

Study Type

OBSERVATIONAL

Enrollment

Start Date

2024-12-01

Completion Date

2025-12-30

Last Updated

2024-12-04

Healthy Volunteers

Conditions

Hepatic Fibrosis

Interventions

DIAGNOSTIC_TEST

serum Adiponectine and Resistin

corrolation between serum adiponectin and Resistin levels and degree of hepatic fibrosis